Zacks: Cantel Medical Corp. (NYSE:CMD) Given $120.00 Average Price Target by Analysts

Shares of Cantel Medical Corp. (NYSE:CMD) have earned a consensus broker rating score of 2.50 (Hold) from the four brokers that cover the company, Zacks Investment Research reports. Three research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company.

Brokers have set a 12 month consensus price objective of $120.00 for the company and are predicting that the company will post $0.61 earnings per share for the current quarter, according to Zacks. Zacks has also given Cantel Medical an industry rank of 104 out of 256 based on the ratings given to its competitors.

NYSE:CMD traded down $0.41 on Friday, hitting $80.70. 277,254 shares of the stock were exchanged, compared to its average volume of 249,091. The firm has a market capitalization of $3.39 billion, a PE ratio of 32.15 and a beta of 1.12. Cantel Medical has a 52 week low of $63.47 and a 52 week high of $99.68. The company has a quick ratio of 1.45, a current ratio of 2.33 and a debt-to-equity ratio of 0.34. The business has a 50-day moving average of $75.37.

Cantel Medical (NYSE:CMD) last announced its quarterly earnings data on Tuesday, June 4th. The company reported $0.55 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.55. The firm had revenue of $228.55 million during the quarter, compared to analysts’ expectations of $225.95 million. Cantel Medical had a return on equity of 15.52% and a net margin of 6.95%. Sell-side analysts predict that Cantel Medical will post 2.35 EPS for the current year.

The business also recently announced a Semi-Annual dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Wednesday, July 17th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Tuesday, July 16th. Cantel Medical’s payout ratio is currently 7.97%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Further Reading: Forex

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.